References
- Reichert JM. Marketed therapeutic antibodies compendium. MAbs 2012; 4:413-15; PMID:22531442; http://dx.doi.org/10.4161/mabs.19931
- Zola H, Swart B. The human leucocyte differentiation antigens (HLDA) workshops: the evolving role of antibodies in research, diagnosis and therapy. Cell Res 2005; 15:691-94; PMID:16212875; http://dx.doi.org/10.1038/sj.cr.7290338
- Berglund L, Bjorling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA, Persson A, Ottosson J, Wernerus H, Nilsson P et al. A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics 2008; 7:2019-27; PMID:18669619; http://dx.doi.org/10.1074/mcp.R800013-MCP200
- Asplund A, Edqvist PH, Schwenk JM, Ponten F. Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research. Proteomics 2012; 12:2067-77; PMID:22623277; http://dx.doi.org/10.1002/pmic.201100504
- Mersmann M, Meier D, Mersmann J, Helmsing S, Nilsson P, Graslund S, Colwill K, Hust M, Dubel S. Towards proteome scale antibody selections using phage display. N Biotechnol 2010; 27:118-28; PMID:19883803; http://dx.doi.org/10.1016/j.nbt.2009.10.007
- Bradbury A, Pluckthun A. Reproducibility: Standardize antibodies used in research. Nature 2015; 518:27-29; PMID:25652980; http://dx.doi.org/10.1038/518027a
- Kalyuzhny AE. The dark side of the immunohistochemical moon: industry. J Histochem Cytochem 2009; 57:1099-101; PMID:19755714; http://dx.doi.org/10.1369/jhc.2009.954867
- Saper CB. An open letter to our readers on the use of antibodies. J Comp Neurol 2005; 493:477-78; PMID:16304632; http://dx.doi.org/10.1002/cne.20839
- Couchman JR. Commercial antibodies: the good, bad, and really ugly. J Histochem Cytochem 2009; 57:7-8; PMID:18854593; http://dx.doi.org/10.1369/jhc.2008.952820
- Baker M. Reproducibility crisis: Blame it on the antibodies. Nature 2015; 521:274-76; PMID:25993940; http://dx.doi.org/10.1038/521274a
- Rhodes KJ, Trimmer JS. Antibodies as valuable neuroscience research tools versus reagents of mass distraction. J Neurosci 2006; 26:8017-20; PMID:16885215; http://dx.doi.org/10.1523/JNEUROSCI.2728-06.2006
- Bucur O, Pennarun B, Stancu AL, Nadler M, Muraru MS, Bertomeu T, Khosravi-Far R. Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP. Apoptosis 2013; 18:1154-62; PMID:23917691; http://dx.doi.org/10.1007/s10495-013-0880-0
- Rhodes KJ, Trimmer JS. Antibody-based validation of CNS ion channel drug targets. J Gen Physiol 2008; 131:407-13; PMID:18411328; http://dx.doi.org/10.1085/jgp.200709926
- Michel MC, Wieland T, Tsujimoto G. How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 2009; 379:385-58; PMID:19172248; http://dx.doi.org/10.1007/s00210-009-0395-y
- Pradidarcheep W, Labruyere WT, Dabhoiwala NF, Lamers WH. Lack of specificity of commercially available antisera: better specifications needed. J Histochem Cytochem 2008; 56:1099-111; PMID:18796405; http://dx.doi.org/10.1369/jhc.2008.952101
- Ramos-Vara JA, Kiupel M, Baszler T, Bliven L, Brodersen B, Chelack B, Czub S, Del Piero F, Dial S, Ehrhart EJ et al. Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories. J Vet Diagn Invest 2008; 20:393-413; PMID:18599844; http://dx.doi.org/10.1177/104063870802000401
- Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm D. Antibody validation. Biotechniques 2010; 48:197-209; PMID:20359301; http://dx.doi.org/10.2144/000113382
- Howat WJ, Lewis A, Jones P, Kampf C, Ponten F, van der Loos CM, Gray N, Womack C, Warford A. Antibody validation of immunohistochemistry for biomarker discovery: Recommendations of a consortium of academic and pharmaceutical based histopathology researchers. Methods 2014; 70:34-38; PMID:24525140; http://dx.doi.org/10.1016/j.ymeth.2014.01.018
- Algenas C, Agaton C, Fagerberg L, Asplund A, Bjorling L, Bjorling E, Kampf C, Lundberg E, Nilsson P, Persson A et al. Antibody performance in western blot applications is context-dependent. Biotechnol J 2014; 9:435-45; PMID:24403002; http://dx.doi.org/10.1002/biot.201300341
- Mannsperger HA, Uhlmann S, Schmidt C, Wiemann S, Sahin O, Korf U. RNAi-based validation of antibodies for reverse phase protein arrays. Proteome Sci 2010; 8:69; PMID:21182776; http://dx.doi.org/10.1186/1477-5956-8-69
- Egelhofer TA, Minoda A, Klugman S, Lee K, Kolasinska-Zwierz P, Alekseyenko AA, Cheung MS, Day DS, Gadel S, Gorchakov AA et al. An assessment of histone-modification antibody quality. Nat Struct Mol Biol 2011; 18:91-93; PMID:21131980; http://dx.doi.org/10.1038/nsmb.1972
- Helsby MA, Fenn JR, Chalmers AD. Reporting research antibody use: how to increase experimental reproducibility. F1000Res 2013; 2:153; PMID:24358895
- Gore AC. Editorial: antibody validation requirements for articles published in endocrinology. Endocrinology 2013; 154:579-80; PMID:23338708; http://dx.doi.org/10.1210/en.2012-2222
- Brown PJ, Kagaya R, Banham AH. Characterization of human FOXP1 isoform 2, using monoclonal antibody 4E3-G11, and intron retention as a tissue-specific mechanism generating a novel FOXP1 isoform. Histopathology 2008; 52:632-37; PMID:18312343; http://dx.doi.org/10.1111/j.1365-2559.2008.02990.x
- Banham AH, Lyne L, Scase TJ, Blacklaws BA. Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species. Vet Immunol Immunopathol 2009; 127:376-81; PMID:19084279; http://dx.doi.org/10.1016/j.vetimm.2008.10.328
- Vira S, Mekhedov E, Humphrey G, Blank PS. Fluorescent labelled antibodies – balancing functionality and degree of labelling. Anal Biochem 2010; 402:146-150; PMID:20362543; http://dx.doi.org/10.1016/j.ab.2010.03.036
- Pulford K, Banham AH, Lyne L, Jones M, Ippolito GC, Liu H, Tucker PW, Roncador G, Lucas E, Ashe S et al. The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. Leukemia 2006; 20:1439-41; PMID:16710303; http://dx.doi.org/10.1038/sj.leu.2404260
- Shi S, Hida A, McGuinness OP, Wasserman DH, Yamazaki S, Johnson CH. Circadian clock gene Bmal1 is not essential; functional replacement with its paralog, Bmal2. Curr Biol 2010; 20:316-21; PMID:20153195; http://dx.doi.org/10.1016/j.cub.2009.12.034
- Major SM, Nishizuka S, Morita D, Rowland R, Sunshine M, Shankavaram U, Washburn F, Asin D, Kouros-Mehr H, Kane D et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. BMC Bioinformatics 2006; 7:192; PMID:16600027; http://dx.doi.org/10.1186/1471-2105-7-192
- Bjorling E, Uhlen M. Antibodypedia, a portal for sharing antibody and antigen validation data. Mol Cell Proteomics 2008; 7:2028-37; PMID:18667413; http://dx.doi.org/10.1074/mcp.M800264-MCP200
- Taussig MJ, Stoevesandt O, Borrebaeck CA, Bradbury AR, Cahill D, Cambillau C, de Daruvar A, Dubel S, Eichler J, Frank R et al. ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods 2007; 4:13-7; PMID:17195019; http://dx.doi.org/10.1038/nmeth0107-13
- Gloriam DE, Orchard S, Bertinetti D, Bjorling E, Bongcam-Rudloff E, Borrebaeck CA, Bourbeillon J, Bradbury AR, de Daruvar A, Dubel S et al. A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics 2009; 9:1-10; PMID:19674966; http://dx.doi.org/10.1074/mcp.M900185-MCP200